However, previous studies have demonstrated that restricted CD4+ T cell primary histocompatibility complex class II (MHC-II) is required for protective immunity by vaccines, which enhance clearance of chlamydial infection by producing IFN-γ [27,28]. Here, CD4 is linked to chlamydia trachomatis infectious disease.